Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

BACKGROUND: Influenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events (irAEs) among patients on immune checkpoint inhibitors (ICIs). Myocarditis is an uncommon but serio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Awadalla, Magid, Golden, Doll Lauren Alexandra, Mahmood, Syed S., Alvi, Raza M., Mercaldo, Nathaniel D., Hassan, Malek Z. O., Banerji, Dahlia, Rokicki, Adam, Mulligan, Connor, Murphy, Sean P. T., Jones-O’Connor, Maeve, Cohen, Justine V., Heinzerling, Lucie M., Armanious, Merna, Sullivan, Ryan J., Damrongwatanasuk, Rongras, Chen, Carol L., Gupta, Dipti, Kirchberger, Michael C., Moslehi, Javid J., Shah, Sachin P., Ganatra, Sarju, Thavendiranathan, Paaladinesh, Rizvi, Muhammad A., Sahni, Gagan, Lyon, Alexander R., Tocchetti, Carlo G., Mercurio, Valentina, Thuny, Franck, Ederhy, Stephane, Mahmoudi, Michael, Lawrence, Donald P., Groarke, John D., Nohria, Anju, Fradley, Michael G., Reynolds, Kerry L., Neilan, Tomas G.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6387531/
https://ncbi.nlm.nih.gov/pubmed/30795818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0535-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados